frozen-form mic panels (JMI Laboratories)
90
Structured Review
JMI Laboratories
frozen-form mic panels
Frozen Form Mic Panels, supplied by JMI Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reference+mic+panels+include+cefiderocol/mic+panels/pmc06437505-133-35-40
Average 90 stars, based on 1 article reviews
Frozen Form Mic Panels, supplied by JMI Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reference+mic+panels+include+cefiderocol/mic+panels/pmc06437505-133-35-40
Average 90 stars, based on 1 article reviews
frozen-form mic panels - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018-2020). Article Snippet: Ceftaroline and comparators were tested against 9,268 Staphylococcus aureus isolates from 33 United States hospitals (2018 2020).. Ceftaroline (MIC50/90, 0.25/1 mg/L) susceptibility ranged from 95.4% (pneumonia) to 98.5% (skin and skin structure) and was 97.2% overall.. Ceftaroline retained potent and broad-spectrum activity against methicillin-resistant isolates, with a 93.4% overall susceptibility. Article Title: Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016–19) Article Snippet: Validated Article Title: Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacterales Article Snippet: Validated Article Title: Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020-2022). Article Snippet: Validated MIC panels (frozen-form) were manufactured at Element Iowa City ( Article Title: 7-Year (2015-21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanisms. Article Snippet: Objectives: Lefamulin (Xenleta), a pleuromutilin antibiotic, was approved for the oral and IV treatment of community-acquired bacterial pneumonia (CABP) in adults in 2019/2020.. This study evaluated the in vitro activity of lefamulin and comparators against 19 584 unique bacterial isolates collected from patients with communityacquired respiratory tract infections and hospitalized patients with pneumonia within the global SENTRY Antimicrobial Surveillance Program during 2015–21. Article Title: Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020–2022) Article Snippet: Validated Concentration Assay:Article Title: Susceptibility trends of ceftolozane/tazobactam and comparators when tested against European Gram-negative bacterial surveillance isolates collected during 2012-18. Article Snippet: Species identification was confirmed by standard biochemical tests and using the MALDI Biotyper (Bruker Daltonics, Billerica, MA, USA) according to the manufacturer’s instructions, when necessary. .. Broth microdilution testing, conducted according to CLSI methods, determined the antimicrobial susceptibility of ceftolozane/tazobactam (inhibitor at fixed concentration of 4 mg/L) and comparator agents.8 |